Publications by authors named "Christopher A Kerantzas"

Background: In 2019 the Centers for Disease Control and Prevention (CDC) reported a series of 4 transfusion reactions that resulted from contamination of apheresis platelet products. Products involved in all 4 cases were contaminated with Acinetobacter calcoaceticus-baumannii complex (ACBC) and in 3 products Staphylococcus saprophyticus was found as well. CDC investigation found that bacterial isolates from the cases were genetically related and suggested a common source of contamination.

View Article and Find Full Text PDF

The Coronavirus Disease of 2019 (COVID-19) pandemic has been a challenging event for laboratory medicine and diagnostics manufacturers. We have had to confront numerous unique and previously unthinkable issues on a daily basis in order to continue offering diagnostic testing for not only Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), but other testing that was significantly impacted by supply chain and staffing disruptions related to COVID-19. Out of this tremendously stressful and, at times, chaotic environment, decades of innovations and advances in testing methodologies and instrumentation became essential to handle the overwhelming volume of samples with clinically appropriate turn-around-time.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to address delays in reporting cerebrospinal fluid (CSF) Gram stains for meningitis diagnosis by monitoring the turnaround time (TAT) and implementing a quality management program to improve efficiency.
  • - By reviewing CSF specimens from 2016 to 2020 and making changes like monthly TAT reviews and better shift communication, the lab was able to reduce the percentage of samples with TAT over 60 minutes from 27.3% to 9.89%.
  • - The implemented changes resulted in a significant decrease in median TAT by 9 minutes and improved consistency across all shifts, demonstrating that workflow adjustments can enhance efficiency without incurring high costs.
View Article and Find Full Text PDF

Beta-D-glucan (BDG) testing can expedite the diagnosis of invasive fungal infections in immunocompromised hosts. Elevated BDG levels have been reported in both studies assessing cross-reactivity with spp. and published cases of patients with nocardiosis, but there is little data on this association in solid organ transplantation (SOT) recipients.

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated a tissue-based PCR test for diagnosing Mycobacterium tuberculosis (MTB) compared to traditional methods like AFB smear, culture, and Xpert™ MTB/RIF.
  • - Over 8 years, the PCR test showed 100% positivity in confirmed/probable MTB cases, outperformed AFB cultures (73% positivity), and had faster results (average 4.3 days vs. 21.2 days for culture).
  • - This new PCR method demonstrated improved sensitivity and quicker detection of MTB, particularly in patients strongly suspected of having the infection.
View Article and Find Full Text PDF

Tuberculosis is a global health problem that causes the death of approximately 1.5 million people worldwide each year (WHO, p. 1-126, , 2015).

View Article and Find Full Text PDF

Mycobacterium tuberculosis (Mtb) encodes five type VII secretion systems (T7SS), designated ESX-1-ESX-5, that are critical for growth and pathogenesis. The best characterized is ESX-1, which profoundly impacts host cell interactions. In contrast, the ESX-3 T7SS is implicated in metal homeostasis, but efforts to define its function have been limited by an inability to recover deletion mutants.

View Article and Find Full Text PDF

Unlabelled: Mycobacterium haemophilum is an emerging pathogen associated with a variety of clinical syndromes, most commonly skin infections in immunocompromised individuals. M. haemophilum exhibits a unique requirement for iron supplementation to support its growth in culture, but the basis for this property and how it may shape pathogenesis is unclear.

View Article and Find Full Text PDF